VITA 34 AG
FamiCord AG engages in the collection, processing, cryopreservation, and storage of stem cells from umbilical cord blood and tissue and postnatal tissue in Germany, Poland, Portugal, and internationally. It operates through Subgroup Vita 34 And Subgroup PBKM segments. The company produces and develops advanced therapies, genetic tests, and analyses for third parties. It also develops products and… Read more
VITA 34 AG (VTIAF) - Total Assets
Latest total assets as of September 2025: $159.53 Million USD
Based on the latest financial reports, VITA 34 AG (VTIAF) holds total assets worth $159.53 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
VITA 34 AG - Total Assets Trend (2006–2024)
This chart illustrates how VITA 34 AG’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
VITA 34 AG - Asset Composition Analysis
Current Asset Composition (December 2024)
VITA 34 AG's total assets of $159.53 Million consist of 26.5% current assets and 73.5% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 11.0% |
| Accounts Receivable | $17.42 Million | 11.4% |
| Inventory | $2.93 Million | 1.9% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $13.55 Million | 8.9% |
| Goodwill | $30.66 Million | 20.1% |
Asset Composition Trend (2006–2024)
This chart illustrates how VITA 34 AG's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: VITA 34 AG's current assets represent 26.5% of total assets in 2024, a decrease from 30.4% in 2006.
- Cash Position: Cash and equivalents constituted 11.0% of total assets in 2024, up from 7.9% in 2006.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 28.0% of total assets, a decrease from 48.0% in 2006.
- Asset Diversification: The largest asset category is goodwill at 20.1% of total assets.
VITA 34 AG Competitors by Total Assets
Key competitors of VITA 34 AG based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Xian International Medical Investment Co Ltd
SHE:000516
|
China | CN¥9.79 Billion |
|
Meinian Onehealth Healthcare Holdings Co Ltd
SHE:002044
|
China | CN¥19.57 Billion |
|
Hengkang Medical Group Co Ltd
SHE:002219
|
China | CN¥6.55 Billion |
|
TMC Life Sciences Bhd
KLSE:0101
|
Malaysia | RM1.12 Billion |
|
Optimax Holdings Sdn Bhd
KLSE:0222
|
Malaysia | RM146.00 Million |
|
Cengild Medical Berhad
KLSE:0243
|
Malaysia | RM218.07 Million |
|
DC HEALTHCARE HOLDINGS BERHAD
KLSE:0283
|
Malaysia | RM99.33 Million |
|
Raffles Medical Group Ltd
F:02M1
|
Germany | €1.49 Billion |
VITA 34 AG - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - VITA 34 AG generates 0.54x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - VITA 34 AG is currently not profitable relative to its asset base.
VITA 34 AG - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.68 | 0.76 | 1.85 |
| Quick Ratio | 0.63 | 0.70 | 1.80 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-18.64 Million | $ -12.57 Million | $ 6.73 Million |
VITA 34 AG - Advanced Valuation Insights
This section examines the relationship between VITA 34 AG's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 6.80 |
| Latest Market Cap to Assets Ratio | 0.25 |
| Asset Growth Rate (YoY) | -3.5% |
| Total Assets | $152.74 Million |
| Market Capitalization | $38.21 Million USD |
Valuation Analysis
Below Book Valuation: The market values VITA 34 AG's assets below their book value (0.25 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: VITA 34 AG's assets decreased by 3.5% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for VITA 34 AG (2006–2024)
The table below shows the annual total assets of VITA 34 AG from 2006 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $152.74 Million | -3.55% |
| 2023-12-31 | $158.36 Million | +4.52% |
| 2022-12-31 | $151.51 Million | -14.86% |
| 2021-12-31 | $177.95 Million | +204.37% |
| 2020-12-31 | $58.46 Million | -4.31% |
| 2019-12-31 | $61.10 Million | +3.00% |
| 2018-12-31 | $59.32 Million | -4.27% |
| 2017-12-31 | $61.96 Million | +42.69% |
| 2016-12-31 | $43.42 Million | -0.82% |
| 2015-12-31 | $43.78 Million | +18.15% |
| 2014-12-31 | $37.06 Million | +4.01% |
| 2013-12-31 | $35.63 Million | -2.73% |
| 2012-12-31 | $36.63 Million | +5.43% |
| 2011-12-31 | $34.74 Million | -5.31% |
| 2010-12-31 | $36.69 Million | +17.78% |
| 2009-12-31 | $31.15 Million | +2.78% |
| 2008-12-31 | $30.31 Million | -6.05% |
| 2007-12-31 | $32.26 Million | +24.99% |
| 2006-12-31 | $25.81 Million | -- |